Preventing coronary artery abnormalities: A need for earlier diagnosis and treatment of Kawasaki disease

Pediatric Infectious Disease Journal

Volumn 31, Issue 12, 2012, Pages 1217-1220

  Dominguez, Samuel R ^a   Anderson, Marsha S ^a   El Adawy, Mohammed ^a,b   Glodé, Mary P ^a  

^a Children's Hospital Colorado   (United States)

^b AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Coronary artery abnormalities; Intravenous immunoglobulin; Kawasaki disease

Indexed keywords

IMMUNOGLOBULIN;

ARTICLE; CHILD; CLINICAL EXAMINATION; CLINICAL FEATURE; CONJUNCTIVITIS; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; CORONARY ARTERY DISEASE; CORONARY ARTERY ECTASIA; DEMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE DURATION; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFANT; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MUCOCUTANEOUS LYMPH NODE SYNDROME; MUCOSAL DISEASE; PEDIATRIC HOSPITAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RASH; SCORING SYSTEM; TREATMENT INDICATION; TREATMENT RESPONSE; UNITED STATES;

CHILD, PRESCHOOL; COLORADO; CORONARY ARTERY DISEASE; CORONARY VESSELS; ECHOCARDIOGRAPHY; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RETROSPECTIVE STUDIES;

EID: 84870908735     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318266bcf9     Document Type: Article

References (20)

1. Burns JC, Glodé M P. Kawasaki syndrome. Lancet. 2004;364:533-544.
2. Newburger J W, Takahashi M, Gerber MA, et al. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004;114:1708-1733.
3. Dominguez SR, Friedman K, Seewald R, et al. Kawasaki disease in a pediatric intensive care unit: a case-control study. Pediatrics. 2008;122:e786- e790.
4. Newburger J W, Takahashi M, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med. 1986;315:341-347.
5. Newburger J W, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med. 1991;324:1633-1639.
6. Song D, Yeo Y, Ha K, et al. Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age. Eur J Pediatr. 2009;168: 1315-1321.
7. Son MB, Gauvreau K, Ma L, et al. Treatment of Kawasaki disease: analysis of 27 US pediatric hospitals from 2001 to 2006. Pediatrics. 2009; 124:1-8.
8. McCrindle B W, Li JS, Minich LL, et al. Pediatric Heart Network Investigators. Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation. 2007;116:174-179.
9. Bratincsak A, Reddy VD, Purohit PJ, et al Coronary artery dilation in acute kawasaki disease and acute illnesses associated with Fever. Pediatr Infect Dis J. 2012;31:924-926.
10. Newburger J W, Takahashi M, Gerber MA, et al. Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease; Council on Cardiovascular Disease in the Young; American Heart Association; American Academy of Pediatrics. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110:2747-2771.
11. Yanagawa H, Nakamura Y, Yashiro M, et al. Results of the nationwide epidemiologic survey of Kawasaki disease in 1995 and 1996 in Japan. Pediatrics. 1998;102:E65.
12. Yanagawa H, Nakamura Y, Yashiro M, et al. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics. 2001;107:E33.
13. Yellen ES, Gauvreau K, Takahashi M, et al. Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease. Pediatrics. 2010;125:e234-e241.
14. Kanegaye JT, Wilder MS, Molkara D, et al. Recognition of a Kawasaki disease shock syndrome. Pediatrics. 2009;123:e783-e789.
15. Belay ED, Maddox RA, Holman RC, et al. Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003. Pediatr Infect Dis J. 2006;25:245-249.
16. Sudo D, Monobe Y, Yashiro M, et al. Case-control study of giant coronary aneurysms due to Kawasaki disease: the 19th nationwide survey. Pediatr Int. 2010;52:790-794.
17. Kim T, Choi W, Woo C W, et al. Predictive risk factors for coronary artery abnormalities in Kawasaki disease. Eur J Pediatr. 2007;166:421-425.
18. Honkanen VE, McCrindle BW, Laxer RM, et al. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease. Pediatr Cardiol. 2003;24:122-126.
19. Sabharwal T, Manlhiot C, Benseler SM, et al. Comparison of factors associated with coronary artery dilation only versus coronary artery aneurysms in patients with Kawasaki disease. Am J Cardiol. 2009;104:1743-1747.
20. Beiser AS, Takahashi M, Baker AL, et al. A predictive instrument for coronary artery aneurysms in Kawasaki disease. US Multicenter Kawasaki Disease Study Group. Am J Cardiol. 1998;81:1116-1120.